ECM
CLVS
Endurant Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-30,500
| Closed | -$1.39M | – | 88 |
|
|
2018
Q2 | $1.39M | Sell |
30,500
-2,600
| -8% | -$118K | 0.6% | 41 |
|
|
2018
Q1 | $1.75M | Sell |
33,100
-34,550
| -51% | -$1.82M | 0.65% | 39 |
|
|
2017
Q4 | $4.6M | Buy |
67,650
+10,900
| +19% | +$741K | 1.41% | 33 |
|
|
2017
Q3 | $4.68M | Buy |
56,750
+25,100
| +79% | +$2.07M | 1.42% | 25 |
|
|
2017
Q2 | $2.96M | Sell |
31,650
-200
| -0.6% | -$18.7K | 0.84% | 35 |
|
|
2017
Q1 | $2.03M | Buy |
31,850
+13,450
| +73% | +$856K | 0.65% | 44 |
|
|
2016
Q4 | $817K | Buy |
18,400
+10,100
| +122% | +$448K | 0.34% | 56 |
|
|
2016
Q3 | $299K | Buy |
+8,300
| New | +$299K | 0.11% | 91 |
|